40 results on '"Bolla, C."'
Search Results
2. SEPTIC EPISODES CAUSED BY ACINETOBACTER BAUMANNII, KLEBSIELLA PNEUMONIAE AND PSEUDOMONAS AERUGINOSA IN A TERTIARY HOSPITAL IN 2018-2020: TRENDS AND CONSIDERATIONS
- Author
-
Garlasco, J., primary, Bolla, C., additional, Beqiraj, I., additional, Marino, E., additional, Zanelli, C., additional, Gualco, C., additional, Rocchetti, A., additional, Zotti, C., additional, and Gianino, M., additional
- Published
- 2023
- Full Text
- View/download PDF
3. Metabolic syndrome and body weight in people living with HIV infection: analysis of differences observed in three different cohort studies over a decade
- Author
-
Taramasso L., Bonfanti P., Ricci E., Maggi P., Orofino G., Squillace N., Menzaghi B., Madeddu G., Molteni C., Vichi F., Riguccini E., Saracino A., Santoro C., Guastavigna M., Francisci D., Di Biagio A., De Socio G. V., Sarchi E., Chichino G., Bolla C., Bellacosa C., Angarano G., Calza L., Farinazzo M., Angioni G., Gussio M., Celesia B. M., Falasca K., Mastroianni A., Guadagnino G., Salomoni E., Martinelli C., Dentone C., Bassetti M., Cenderello G., Pellicano G. F., Nunnari G., Valsecchi L., Cordier L., Parisini S., Rizzardini G., Rusconi S., Conti F., Bandera A., Gori A., Motta D., Puoti M., Migliorino G. M., Martini S., Cascio A., Trizzino M., Gulminetti R., Nofri M., Cibelli D., Parruti G., Mameli M. S., Taramasso L., Bonfanti P., Ricci E., Maggi P., Orofino G., Squillace N., Menzaghi B., Madeddu G., Molteni C., Vichi F., Riguccini E., Saracino A., Santoro C., Guastavigna M., Francisci D., Di Biagio A., De Socio G.V., Sarchi E., Chichino G., Bolla C., Bellacosa C., Angarano G., Calza L., Farinazzo M., Angioni G., Gussio M., Celesia B.M., Falasca K., Mastroianni A., Guadagnino G., Salomoni E., Martinelli C., Dentone C., Bassetti M., Cenderello G., Pellicano G.F., Nunnari G., Valsecchi L., Cordier L., Parisini S., Rizzardini G., Rusconi S., Conti F., Bandera A., Gori A., Motta D., Puoti M., Migliorino G.M., Martini S., Cascio A., Trizzino M., Gulminetti R., Nofri M., Cibelli D., Parruti G., Mameli M.S., Taramasso, L, Bonfanti, P, Ricci, E, Maggi, P, Orofino, G, Squillace, N, Menzaghi, B, Madeddu, G, Molteni, C, Vichi, F, Riguccini, E, Saracino, A, Santoro, C, Guastavigna, M, Francisci, D, Di Biagio, A, De Socio, G, Taramasso, Lucia, Bonfanti, Paolo, Ricci, Elena, Maggi, Paolo, Orofino, Giancarlo, Squillace, Nicola, Menzaghi, Barbara, Madeddu, Giordano, Molteni, Chiara, Vichi, Francesca, Riguccini, Erika, Saracino, Annalisa, Santoro, Carmen, Guastavigna, Marta, Francisci, Daniela, Di Biagio, Antonio, and De Socio, Giuseppe Vittorio
- Subjects
Adult ,Male ,dyslipidaemia ,antiretroviral therapy ,HIV Infections ,Overweight ,Logistic regression ,Body Mass Index ,Cohort Studies ,Prevalence ,medicine ,overweight ,Humans ,Pharmacology (medical) ,Metabolic Syndrome ,business.industry ,Health Policy ,Incidence (epidemiology) ,Body Weight ,HIV ,weight gain ,Odds ratio ,Middle Aged ,medicine.disease ,Confidence interval ,metabolic syndrome ,Cross-Sectional Studies ,Infectious Diseases ,Metabolic syndrome ,medicine.symptom ,business ,Weight gain ,Demography ,Cohort study - Abstract
Objectives: The aim of this study was to assess the incidence of being overweight and metabolic syndrome (MS) among people living with HIV (PHIV) in three different cross-sectional studies conducted over three different periods: 2005, 2011 and 2015. Methods: This was a multi-centre, nationwide study. Data were collected in three studies from the CISAI group - SIMOne, HIV-HY and STOPSHIV - and included a total of 3014 PHIV. Logistic regression [odds ratio (OR), 95% confidence interval (CI)] was used to account for age and gender difference among three groups when comparing MS prevalence and being overweight; potential confounders were accounted for by including them in the regression equation. Results: Overall, the mean age was 46.9±10.2years, and men comprised 73.3% of participants. Comparing 2005, 2011 and 2015, MS was present in 34.5%, 33.0% and 29.3% of PHIV, respectively. Adjusted OR for MS was 0.64 (95% CI: 0.52-0.78) in 2011 and 0.56 (95% CI: 0.46-0.69) in 2015 compared with 2005, while BMI (kg/m2 ) increased from 23.6 in 2005, 24.5 in 2011 and 24.5 in 2015, with a concomitant increase of being overweight from 29.4% to 39.5% to 39.6% (p 
- Published
- 2021
4. Adherence to 2015 ESC Guidelines for the Treatment of Infective Endocarditis: A Retrospective Multicentre Study (LEIOT Study)
- Author
-
Pallotto, C., Bolla, C., Penpa, S., Genga, G., Sarda, C., Svizzeretto, E., Tommasi, A., Stolaj, E., Salvaderi, A., Piceni, G., Maconi, A., Chichino, G., and Francisci, D.
- Subjects
infective endocarditis ,daptomycin ,antibiotic treatment ,adherence ,guidelines ,gentamicin ,rifampin - Published
- 2023
5. Impact of sepses caused by three Multi-Drug Resistant bacteria in a tertiary hospital in 2018-2020
- Author
-
Garlasco, J, primary, Beqiraj, I, additional, Bolla, C, additional, Marino, EMI, additional, Zanelli, C, additional, Rocchetti, A, additional, and Gianino, MM, additional
- Published
- 2022
- Full Text
- View/download PDF
6. Down Syndrome and COVID-19: not always a poor prognosis
- Author
-
Parisini, A., primary, Boni, S., additional, Vacca, E Blasi, additional, Del Puente, F., additional, Feasi, M., additional, Bobbio, N., additional, Prinapori, R., additional, Bolla, C., additional, Castellaneta, M., additional, Pontali, E., additional, and Chichino, G., additional
- Published
- 2022
- Full Text
- View/download PDF
7. Simple parameters from complete blood count predict in-hospital mortality in covid-19
- Author
-
Bellan, M., Azzolina, D., Hayden, E., Gaidano, G., Pirisi, M., Acquaviva, A., Aimaretti, G., Valletti, P. A., Angilletta, R., Arioli, R., Avanzi, G. C., Avino, G., Balbo, P. E., Baldon, G., Baorda, F., Barbero, E., Baricich, A., Barini, M., Barone-Adesi, F., Battistini, S., Beltrame, M., Bertoli, M., Bertolin, S., Bertolotti, M., Betti, M., Bobbio, F., Boffano, P., Boglione, L., Borre, S., Brucoli, M., Calzaducca, E., Cammarata, E., Cantaluppi, V., Cantello, R., Capponi, A., Carriero, A., Casciaro, G. F., Castello, L. M., Ceruti, F., Chichino, G., Chirico, E., Cisari, C., Cittone, M. G., Colombo, C., Comi, C., Croce, E., Daffara, T., Danna, P., Corte, F. D., de Vecchi, S., Dianzani, U., Benedetto, D. D., Esposto, E., Faggiano, F., Falaschi, Z., Ferrante, D., Ferrero, A., Gagliardi, I., Galbiati, A., Gallo, S., Garavelli, P. L., Gardino, C. A., Garzaro, M., Gastaldello, M. L., Gavelli, F., Gennari, A., Giacomini, G. M., Giacone, I., Via, V. G., Giolitti, F., Gironi, L. C., Gramaglia, C., Grisafi, L., Inserra, I., Invernizzi, M., Krengli, M., Labella, E., Landi, I. C., Landi, R., Leone, I., Lio, V., Lorenzini, L., Maconi, A., Malerba, M., Manfredi, G. F., Martelli, M., Marzari, L., Marzullo, P., Mennuni, M., Montabone, C., Morosini, U., Mussa, M., Nerici, I., Nuzzo, A., Olivieri, C., Padelli, S. A., Panella, M., Parisini, A., Pasche, A., Patrucco, F., Patti, G., Pau, A., Pedrinelli, A. R., Percivale, I., Ragazzoni, L., Re, R., Rigamonti, C., Rizzi, E., Rognoni, A., Roveta, A., Salamina, L., Santagostino, M., Saraceno, M., Savoia, P., Sciarra, M., Schimmenti, A., Scotti, L., Spinoni, E., Smirne, C., Tarantino, V., Tillio, P. A., Tonello, S., Vaschetto, R., Vassia, V., Zagaria, D., Zavattaro, E., Zeppegno, P., Zottarelli, F., Sainaghi, P. P., Aiosa, G., Airoldi, A., Barco, A., Bargiacchi, O., Bazzano, S., Berni, P., Bianchi, B., Bianco, S., Biffi, S., Binda, V., Bolgeo, T., Bolla, C., Bonato, V., Bonizzoni, G., Bragantini, A., Brustia, D., Bullara, V., Burlone, M., Brustia, F., Caccia, S., Calareso, A., Cammarota, G., Cancelliere, L., Carbone, R., Cassinari, A., Ceriani, E., Cena, T., Clivati, E., Collimedaglia, L., Colombatto, A., Cornella, C., Costanzo, M., Croce, A., de Benedittis, C., Delorenzi, S., Dionisio, R., Donato, P., Esposito, M., Fangazio, S., Feggi, A., Ferrillo, S., Foci, V., Fra, G. P., Gaggino, C., Gambaro, E., Gattoni, E., Gattoni, L., Giacchero, F., Gianfreda, R., Giubertoni, A., Grecu, L., Grossi, F., Guglielmetti, G., Guido, S., Iannantuoni, G., Ingrao, S., Jona, A., Lazzarich, E., Lissandrin, R., Maduli, E., Magne, F., Mantia, E., Marangon, D., Massara, M., Matino, E., Mauri, M. G., Menegatti, M., Moglia, R., Molinari, R., Morelli, S., Morlino, P., Naldi, P., Nebbiolo, C., Omodeo, P., Palmieri, D., Panero, A., Parodi, M., Pedrazzoli, R., Pelazza, C., Penpa, S., Perucca, R., Pirovano, A., Pittau, S., Pochetti, P., Poletti, F., Polla, B., Prandi, P., Prodam, F., Prosperini, P., Puma, A., Quaglia, M., Raie, A., Rapetti, R., Ravera, S., Re, A., Reale, M., Rossati, A., Rossi, M., Rossi, P., Rostagno, R., Salomoni, G., Sama, M. T., Sarchi, E., Sarcoli, M., Sarda, C., Sguazzotti, I., Soddu, D., Sola, D., Stobbione, P., Todoerti, M., Vallese, G. C., Varrasi, C., Veia, A., Vignazia, G. L., Zanotti, I., Zecca, E., Zichittella, D., Zisa, G., and Zoppis, E.
- Subjects
Adult ,Male ,medicine.medical_specialty ,Medicine (General) ,Multivariate analysis ,Article Subject ,Clinical Decision Rules, COVID-19, Prognosis, Blood Cell Count, Hospital Mortality, Severity of Illness Index ,Clinical Biochemistry ,Asymptomatic ,Severity of Illness Index ,NO ,R5-920 ,Internal medicine ,Clinical Decision Rules ,Severity of illness ,Genetics ,80 and over ,Medicine ,Humans ,Hospital Mortality ,Molecular Biology ,Aged ,Retrospective Studies ,Aged, 80 and over ,medicine.diagnostic_test ,business.industry ,Biochemistry (medical) ,Complete blood count ,COVID-19 ,Retrospective cohort study ,Red blood cell distribution width ,General Medicine ,Odds ratio ,Middle Aged ,Prognosis ,Female ,Italy ,Multivariate Analysis ,Blood Cell Count ,Cohort ,medicine.symptom ,business ,Research Article - Abstract
Introduction. The clinical course of Coronavirus Disease 2019 (COVID-19) is highly heterogenous, ranging from asymptomatic to fatal forms. The identification of clinical and laboratory predictors of poor prognosis may assist clinicians in monitoring strategies and therapeutic decisions. Materials and Methods. In this study, we retrospectively assessed the prognostic value of a simple tool, the complete blood count, on a cohort of 664 patients ( F 260; 39%, median age 70 (56-81) years) hospitalized for COVID-19 in Northern Italy. We collected demographic data along with complete blood cell count; moreover, the outcome of the hospital in-stay was recorded. Results. At data cut-off, 221/664 patients (33.3%) had died and 453/664 (66.7%) had been discharged. Red cell distribution width (RDW) ( χ 2 10.4; p < 0.001 ), neutrophil-to-lymphocyte (NL) ratio ( χ 2 7.6; p = 0.006 ), and platelet count ( χ 2 5.39; p = 0.02 ), along with age ( χ 2 87.6; p < 0.001 ) and gender ( χ 2 17.3; p < 0.001 ), accurately predicted in-hospital mortality. Hemoglobin levels were not associated with mortality. We also identified the best cut-off for mortality prediction: a NL ratio > 4.68 was characterized by an odds ratio for in-hospital mortality OR = 3.40 (2.40-4.82), while the OR for a RDW > 13.7 % was 4.09 (2.87-5.83); a platelet count > 166,000 /μL was, conversely, protective (OR: 0.45 (0.32-0.63)). Conclusion. Our findings arise the opportunity of stratifying COVID-19 severity according to simple lab parameters, which may drive clinical decisions about monitoring and treatment.
- Published
- 2021
8. Clinical Usefulness of ELISPOT Assay on Pericardial Fluid in a Case of Suspected Tuberculous Pericarditis
- Author
-
Biglino, A., Crivelli, P., Concialdi, E., Bolla, C., and Montrucchio, G.
- Published
- 2008
- Full Text
- View/download PDF
9. Factors Associated With Weight Gain in People Treated With Dolutegravir
- Author
-
Taramasso, L, Bonfanti, P, Ricci, E, Orofino, G, Squillace, N, Menzaghi, B, De Socio, G, Madeddu, G, Pellicanò, G, Pagnucco, L, Celesia, B, Calza, L, Conti, F, Martinelli, C, Valsecchi, L, Cascio, A, Bolla, C, Maggi, P, Vichi, F, Dentone, C, Angioni, G, Mastroianni, A, Falasca, K, Cenderello, G, Di Biagio, A, Taramasso, Lucia, Bonfanti, Paolo, Ricci, Elena, Orofino, Giancarlo, Squillace, Nicola, Menzaghi, Barbara, De Socio, Giuseppe Vittorio, Madeddu, Giordano, Pellicanò, Giovanni Francesco, Pagnucco, Layla, Celesia, Benedetto Maurizio, Calza, Leonardo, Conti, Federico, Martinelli, Canio Vito, Valsecchi, Laura, Cascio, Antonio, Bolla, Cesare, Maggi, Paolo, Vichi, Francesca, Dentone, Chiara, Angioni, Goffredo, Mastroianni, Antonio, Falasca, Katia, Cenderello, Giovanni, Di Biagio, Antonio, Taramasso, L, Bonfanti, P, Ricci, E, Orofino, G, Squillace, N, Menzaghi, B, De Socio, G, Madeddu, G, Pellicanò, G, Pagnucco, L, Celesia, B, Calza, L, Conti, F, Martinelli, C, Valsecchi, L, Cascio, A, Bolla, C, Maggi, P, Vichi, F, Dentone, C, Angioni, G, Mastroianni, A, Falasca, K, Cenderello, G, Di Biagio, A, Taramasso, Lucia, Bonfanti, Paolo, Ricci, Elena, Orofino, Giancarlo, Squillace, Nicola, Menzaghi, Barbara, De Socio, Giuseppe Vittorio, Madeddu, Giordano, Pellicanò, Giovanni Francesco, Pagnucco, Layla, Celesia, Benedetto Maurizio, Calza, Leonardo, Conti, Federico, Martinelli, Canio Vito, Valsecchi, Laura, Cascio, Antonio, Bolla, Cesare, Maggi, Paolo, Vichi, Francesca, Dentone, Chiara, Angioni, Goffredo, Mastroianni, Antonio, Falasca, Katia, Cenderello, Giovanni, and Di Biagio, Antonio
- Abstract
Background An unexpected excess in weight gain has recently been reported in the course of dolutegravir (DTG) treatment. The aim of the present study was to investigate whether weight gain differs among different DTG-containing regimens. Methods Adult naïve and experienced people with HIV (PWH) initiating DTG-based antiretroviral therapy (ART) between July 2014 and December 2019 in the Surveillance Cohort Long-Term Toxicity Antiretrovirals (SCOLTA) prospective cohort were included. We used an adjusted general linear model to compare weight change among backbone groups and a Cox proportional hazard regression model to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) for weight increases >10% from baseline. Results A total of 713 participants, 25.3% women and 91% Caucasian, were included. Of these, 195 (27.4%) started DTG as their first ART regimen, whereas 518 (72.6%) were ART-experienced. DTG was associated with abacavir/lamivudine in 326 participants, tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) in 148, boosted protease inhibitors in 60, rilpivirine in 45, lamivudine in 75, and tenofovir alafenamide (TAF)/FTC in 59. At 6 and 12 months, weight gain was highest among PWH on TDF/FTC+DTG and TAF/FTC+DTG. Baseline CD4 <200 cells/mm3 (HR, 1.84; 95% CI, 1.15 to 2.96), being ART-naïve (HR, 2.24; 95% CI, 1.24 to 4.18), and treatment with TDF/FTC+DTG (HR, 1.92; 95% CI, 1.23 to 2.98) or TAF/FTC+DTG (HR, 3.80; 95% CI, 1.75 to 8.23) were associated with weight gain >10% from baseline. Higher weight (HR, 0.97 by 1 kg; 95% CI, 0.96 to 0.99) and female gender (HR, 0.54; 95% CI, 0.33 to 0.88) were protective against weight gain. Conclusions Naïve PWH with lower CD4 counts and those on TAF/FTC or TDF/FTC backbones were at higher risk of weight increase in the course of DTG-based ART.
- Published
- 2020
10. Metabolic syndrome and body weight in people living with HIV infection: analysis of differences observed in three different cohort studies over a decade.
- Author
-
Taramasso, Lucia, Bonfanti, Paolo, Ricci, Elena, Maggi, Paolo, Orofino, Giancarlo, Squillace, Nicola, Menzaghi, Barbara, Madeddu, Giordano, Molteni, Chiara, Vichi, Francesca, Riguccini, Erika, Saracino, Annalisa, Santoro, Carmen, Guastavigna, Marta, Francisci, Daniela, Di Biagio, Antonio, De Socio, Giuseppe Vittorio, Sarchi, E., Chichino, G., and Bolla, C.
- Subjects
HIV infections ,OBESITY ,RESEARCH ,HIV-positive persons ,CONFIDENCE intervals ,MEDICAL cooperation ,METABOLIC syndrome ,DESCRIPTIVE statistics ,LOGISTIC regression analysis ,ODDS ratio ,BODY mass index - Abstract
Objectives: The aim of this study was to assess the incidence of being overweight and metabolic syndrome (MS) among people living with HIV (PHIV) in three different cross‐sectional studies conducted over three different periods: 2005, 2011 and 2015. Methods: This was a multi‐centre, nationwide study. Data were collected in three studies from the CISAI group – SIMOne, HIV‐HY and STOPSHIV – and included a total of 3014 PHIV. Logistic regression [odds ratio (OR), 95% confidence interval (CI)] was used to account for age and gender difference among three groups when comparing MS prevalence and being overweight; potential confounders were accounted for by including them in the regression equation. Results: Overall, the mean age was 46.9 ± 10.2 years, and men comprised 73.3% of participants. Comparing 2005, 2011 and 2015, MS was present in 34.5%, 33.0% and 29.3% of PHIV, respectively. Adjusted OR for MS was 0.64 (95% CI: 0.52–0.78) in 2011 and 0.56 (95% CI: 0.46–0.69) in 2015 compared with 2005, while BMI (kg/m2) increased from 23.6 in 2005, 24.5 in 2011 and 24.5 in 2015, with a concomitant increase of being overweight from 29.4% to 39.5% to 39.6% (p < 0.0001). Conclusions: In recent years, PHIV have had a significantly improved metabolic profile compared with previously, despite increasing weight and BMI. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
11. Epidemiological evaluation of Leishmania infantumzoonotic transmission risk in the recently established endemic area of Northwestern Italy
- Author
-
Ferroglio, E., primary, Battisti, E., additional, Zanet, S., additional, Bolla, C., additional, Concialdi, E., additional, Trisciuoglio, A., additional, Khalili, S., additional, and Biglino, A., additional
- Published
- 2018
- Full Text
- View/download PDF
12. ESGAP inventory of target indicators assessing antibiotic prescriptions: A cross-sectional survey
- Author
-
Howard, P., Huttner, B., Beovic, B., Beraud, G., Kofteridis, D. P., Pardo, J. P., Schouten, J., Pulcini, C., Angioni, G., Arvaniti, K., Barac, A., Bolla, C., Calbo, E., Dyar, O. -J., Fantoni, Massimo, Fjeld, H., Keuleyan, E., Kumar, S., Harhxi, A., Jenkins, D., Maurer, F. P., Messiaen, P., Baranda, M. M., Munoz, P., Orlando, G., Pagani, L., Pepe, F., Gentil, P. R., Pereira, N. M. R., Rodrigues-Bano, J., Skodvin, B., Tangden, T., Vitrat, V., Vlahovic-Palcevski, V., Wechsler-Fordos, A., Zarb, P., Fantoni M. (ORCID:0000-0001-6913-8460), Howard, P., Huttner, B., Beovic, B., Beraud, G., Kofteridis, D. P., Pardo, J. P., Schouten, J., Pulcini, C., Angioni, G., Arvaniti, K., Barac, A., Bolla, C., Calbo, E., Dyar, O. -J., Fantoni, Massimo, Fjeld, H., Keuleyan, E., Kumar, S., Harhxi, A., Jenkins, D., Maurer, F. P., Messiaen, P., Baranda, M. M., Munoz, P., Orlando, G., Pagani, L., Pepe, F., Gentil, P. R., Pereira, N. M. R., Rodrigues-Bano, J., Skodvin, B., Tangden, T., Vitrat, V., Vlahovic-Palcevski, V., Wechsler-Fordos, A., Zarb, P., and Fantoni M. (ORCID:0000-0001-6913-8460)
- Abstract
Background A variety of indicators is commonly used to monitor antibiotic prescriptions as part of national antimicrobial stewardship (AMS) programmes. Objectives To make an inventory of indicators that assess antibiotic prescriptions and are linked to specific targets and incentives, at a national level. Methods A cross-sectional survey (three-item questionnaire) was conducted in 2017 among all ESGAP (ESCMID Study Group for Antimicrobial stewardshiP) members, coming from 23 European countries and 16 non-European countries. Results Almost all (20/23, 87%) European countries belonging to the ESGAP network participated, as well as one non-European country. Computerized systems routinely linking antibiotic prescriptions to clinical diagnoses were reported for only two countries (Turkey and Croatia). Only 6/21 (29%) countries had national indicators with both clear targets and incentives (Bulgaria, Croatia, France, the Netherlands, Norway and Portugal). We identified a total of 21 different indicators used in these countries, 16 concerning inpatients (9 quality indicators and 7 quantity metrics) and 8 concerning outpatients (all quantity metrics); some indicators were used in both settings. Three types of incentives were used: financing mechanism, hospitals' accreditation and public reporting. Some respondents reported that such indicators with both clear targets and incentives were used at a regional level in their country (e.g. Andalusia in Spain and England in the UK). Conclusions National indicators, with clear targets and incentives, are not commonly used in Europe and we observed wide variations between countries regarding the selected indicators, the units of measure and the chosen targets.
- Published
- 2017
13. IMPATTO DI UNA POLITICA DI 'ANTIMICROBIAL STEWARDSHIP' SU CONSUMO DI ANTIBIOTICI E RESISTENZE BATTERICHE PRESSO L’A.O.U - POLICLINICO 'SAN LUIGI GONZAGA', TORINO
- Author
-
Biglino, Alberto, Bolla, C., Montrucchio, G., Moglia, R., Silvaplana, P., Chirillo, M. G., Capano, F., Valle, M., and Degioanni, M.
- Published
- 2012
14. Prevalence and risk factors for Chlamydia trachomatis infection among female medical students and women attending family planning clinics in Northern Italy
- Author
-
Biglino, Alberto, Montrucchio, G., Moglia, R., Concialdi, E., Bolla, C., Tramontano, M., and Ferrero, D. V.
- Published
- 2011
15. Comparison of Copan UriSwab with BD ProbeTec urine preservative transport kit for preservation and detection of CT and NG in the ProbeTec assay
- Author
-
Castriciano, S., Montrucchio, G., Moglia, R., Concialdi, E., Oddone, L., Bolla, C., and Biglino, Alberto
- Published
- 2011
16. Linfadenite da B. Henselae in paziente con pregressa infezione: reinfezione o riattivazione?
- Author
-
Biglino, Alberto, Montrucchio, G., Pitino, A., Degioanni, M., Oddone, L., Bolla, C., and Moglia, R.
- Published
- 2011
17. Alterations of anthropometric and metabolic parameters correlate with early increase in IFN-g and TNF-a production after starting antiretroviral treatment in ART-naive HIV patients
- Author
-
Biglino, Alberto, Brusa, Mt, Bolla, C, Martini, C, Concialdi, E, Mascolo, M, Raineri, G, and Gobber, M.
- Published
- 2006
18. METHOD DEVELOPMENT AND VALIDATION OF UV SPECTROPHOTOMETRIC AND STABILITY INDICATING RP-HPLC METHODS FOR SIMULTANEOUS ESTIMATION OF MOXIFLOXACIN HYDROCHLORIDE AND KETOROLAC TROMETHAMINE IN BULK AND OPTHALMIC DOSAGE FORMS.
- Author
-
Parimi, H., Bolla, C., Gandhi, B. M., Vatchavai, B. R., Kamatham, S. S., and Kolli, S.
- Subjects
- *
DOSAGE forms of drugs , *TREATMENT of eye diseases , *MOXIFLOXACIN , *ACETONITRILE , *SPECTROPHOTOMETRY - Abstract
The main objective of the present work was to develop a simple, precise, accurate and reproducible UV-Spectrophotometric and stability indicating RP-HPLC methods for simultaneous estimation of moxifloxacin HCl (MOX) and ketorolac tromethamine (KET) in bulk and ophthalmic dosage forms. UV Spectrophotometry was carried out by simultaneous equation method using distilled water : acetonitrile (50:50 V/V) as solvent. The wavelengths were found to be 295 nm for MOX and 322 nm for KET. The isobestic point was found to be 308 nm. The linearity range is 2-10 μg/mL for both MOX and KET with correlation co-efficient >0.99. The separation of these two drugs using RP-HPLC was achieved on a SHISHEDO C18, 250×4.6 mm, 5 micron size column with a mobile phase consisting of acetonitrile and acetate buffer (45:55 V/V) at pH 4.0 at a flow rate of 1 mL/min and UV detection at 308 nm. The retention times were observed to be 2.418 and 3.827 minutes for MOX and KET, respectively. Linearity was found to be 10-50 μg/mL for both MOX and KET, respectively. The two developed methods were successfully validated for accuracy, precision, linearity, limit of detection, limit of quantification and robustness. The two developed methods were validated according to ICH guidelines and were found to be with in the limits. The stress testing of the drugs individually was carried out under acidic, alkaline, oxidation, photo-stability and thermal degradation conditions and its degradation products were studied. These two methods could be used for simultaneous estimation of MOX and KET in bulk and ophthalmic dosage forms. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
19. P2-S4.03 Prevalence and risk factors for Chlamydia trachomatis infection among female medical students and women attending family planning clinics in Northern Italy
- Author
-
Biglino, A., primary, Montrucchio, G., additional, Moglia, R., additional, Concialdi, E., additional, Bolla, C., additional, Tramontano, M., additional, and Ferrero, D. V., additional
- Published
- 2011
- Full Text
- View/download PDF
20. P3-S1.31 Comparison of Copan UriSwab with BD ProbeTec urine preservative transport kit for preservation and detection of CT and NG in the ProbeTec assay
- Author
-
Castriciano, S., primary, Montrucchio, G., additional, Moglia, R., additional, Concialdi, E., additional, Oddone, L., additional, Bolla, C., additional, and Biglino, A., additional
- Published
- 2011
- Full Text
- View/download PDF
21. P543 Primary muscle hydatidosis of the thigh in a pregnant woman
- Author
-
Degioanni, M., primary, Maccabruni, A., additional, Bolla, C., additional, Montrucchio, G., additional, and Biglino, A., additional
- Published
- 2007
- Full Text
- View/download PDF
22. THE INFLUENCE OF LIPOIC ACID ON BRIGGS-RAUSCHER OSCILLATING REACTION.
- Author
-
SZABÓ, GABRIELLA, BOLLA, C. S., JÁNOS, LAURA, and RÁCZ, C. S.
- Published
- 2003
23. TEMPERATURE DEPENDENCE OF THE DIOXIMES HYDROLYSIS REACTION RATE.
- Author
-
SZABÓ, G., ZSAKÓ, J., and BOLLA, C. S.
- Published
- 2003
24. INFLUENCE OF IODATE ION CONCENTRATION ON OSCILLATIONS IN THE BRIGGS-RAUSCHER REACTION.
- Author
-
SZABÓ, E., SZABÓ, G., and BOLLA, C. S.
- Published
- 2003
25. KINETIC STUDY ON HYDROLYSIS REACTION OF DIOXIMES.
- Author
-
SZABÓ, G., ZSAKÓ, J., BÂLDEA, I., and BOLLA, C. S.
- Published
- 2003
26. Dog's parasite and zoonotic risk: From old to new 'emergencies' in the North-West of Italy
- Author
-
Ferroglio, E., Romano, A., Passera, S., Antonio D'ANGELO, Guiso, P., Ghiggi, E., Bolla, C., Trisciuoglio, A., and Biglino, A.
27. Epidemiological evaluation of Leishmania infantum zoonotic transmission risk in the recently established endemic area of Northwestern Italy.
- Author
-
Ferroglio, E., Battisti, E., Zanet, S., Bolla, C., Concialdi, E., Trisciuoglio, A., Khalili, S., and Biglino, A.
- Subjects
LEISHMANIA infantum ,EPIDEMIOLOGY ,ZOONOSES ,RESTRICTION fragment length polymorphisms ,SEROPREVALENCE - Abstract
Summary: Leishmania infantum infection had been expanding into new areas due to changes in vector and host biology. Zoonotic visceral leishmaniasis has become endemic in previously unsuitable areas as vectors find favourable climatic conditions and an increasing number of reservoir dogs are moved between traditionally and new endemic areas. Monitoring vector and disease expansion in areas of recent colonization is needed to understand transmission mechanisms and patterns of disease establishment. Here, we studied the infection status of 815 human blood donors and of 803 sympatric dogs from five, newly endemic, areas in Northwestern Italy. In autochthonous dogs, the seroprevalence of anti‐L. infantum antibodies, recorded by Western blot, reached 42.22%, while in humans, the seroprevalence was of 16.81%. No significant correlation between the infection status of dogs and that of their human owners was found, but L. infantum infection was recorded in the different study areas with significant levels of diversity. Restriction fragment length polymorphism showed a high genetic variability of the circulating strains and gave useful insights on patterns of disease establishment into a naïve area. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
28. Factors Associated With Weight Gain in People Treated With Dolutegravir
- Author
-
Federico Conti, Giovanni Francesco Pellicanò, Barbara Menzaghi, Giuseppe Vittorio De Socio, Laura Valsecchi, Giancarlo Orofino, Paolo Bonfanti, Cesare Bolla, Lucia Taramasso, Benedetto Maurizio Celesia, Antonio Di Biagio, Leonardo Calza, Elena Ricci, Francesca Vichi, Antonio Mastroianni, Paolo Maggi, Goffredo Angioni, Giordano Madeddu, Layla Pagnucco, Chiara Dentone, Nicola Squillace, Antonio Cascio, Canio Martinelli, Giovanni Cenderello, Katia Falasca, Taramasso, L, Bonfanti, P, Ricci, E, Orofino, G, Squillace, N, Menzaghi, B, De Socio, Gv, Madeddu, G, Pellicanò, Gf, Pagnucco, L, Celesia, Bm, Calza, L, Conti, F, Martinelli, Cv, Valsecchi, L, Cascio, A, Bolla, C, Maggi, P, Vichi, F, Dentone, C, Angioni, G, Mastroianni, A, Falasca, K, Cenderello, G, Di Biagio, A, Taramasso L., Bonfanti P., Ricci E., Orofino G., Squillace N., Menzaghi B., De Socio G.V., Madeddu G., Pellicano G.F., Pagnucco L., Celesia B.M., Calza L., Conti F., Martinelli C.V., Valsecchi L., Cascio A., Bolla C., Maggi P., Vichi F., Dentonell C., Angioni G., Mastroianni A., Falasca K., Cenderello G., Di Biagio A., De Socio, G, Pellicanò, G, Celesia, B, and Martinelli, C
- Subjects
0301 basic medicine ,medicine.medical_specialty ,Weight gain ,HIV metabolic complications ,030106 microbiology ,HIV metabolic complication ,TDF ,Emtricitabine ,Tenofovir alafenamide ,dolutegravir, HIV metabolic complications, TAF, TDF, weight gain ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Abacavir ,Internal medicine ,medicine ,Major Article ,030212 general & internal medicine ,business.industry ,Weight change ,Lamivudine ,weight gain ,dolutegravir ,Infectious Diseases ,AcademicSubjects/MED00290 ,Oncology ,chemistry ,TAF ,Rilpivirine ,Dolutegravir ,medicine.symptom ,business ,medicine.drug - Abstract
BackgroundAn unexpected excess in weight gain has recently been reported in the course of dolutegravir (DTG) treatment. The aim of the present study was to investigate whether weight gain differs among different DTG-containing regimens.MethodsAdult naïve and experienced people with HIV (PWH) initiating DTG-based antiretroviral therapy (ART) between July 2014 and December 2019 in the Surveillance Cohort Long-Term Toxicity Antiretrovirals (SCOLTA) prospective cohort were included. We used an adjusted general linear model to compare weight change among backbone groups and a Cox proportional hazard regression model to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) for weight increases >10% from baseline.ResultsA total of 713 participants, 25.3% women and 91% Caucasian, were included. Of these, 195 (27.4%) started DTG as their first ART regimen, whereas 518 (72.6%) were ART-experienced. DTG was associated with abacavir/lamivudine in 326 participants, tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) in 148, boosted protease inhibitors in 60, rilpivirine in 45, lamivudine in 75, and tenofovir alafenamide (TAF)/FTC in 59. At 6 and 12 months, weight gain was highest among PWH on TDF/FTC+DTG and TAF/FTC+DTG. Baseline CD4 10% from baseline. Higher weight (HR, 0.97 by 1 kg; 95% CI, 0.96 to 0.99) and female gender (HR, 0.54; 95% CI, 0.33 to 0.88) were protective against weight gain.ConclusionsNaïve PWH with lower CD4 counts and those on TAF/FTC or TDF/FTC backbones were at higher risk of weight increase in the course of DTG-based ART.
- Published
- 2020
29. Use of colistin in adult patients: a cross-sectional study
- Author
-
Giacobbe, Daniele Roberto, Saffioti, Carolina, Losito, Angela Raffaella, Rinaldi, Matteo, Aurilio, Caterina, Bolla, Cesare, Boni, Silvia, Borgia, Guglielmo, Carannante, Novella, Cassola, Giovanni, Ceccarelli, Giancarlo, Corcione, Silvia, Gasperina, Daniela Dalla, De Rosa, Francesco Giuseppe, Dentone, Chiara, Di Bella, Stefano, Di Lauria, Nicoletta, Feasi, Marcello, Fiore, Marco, Fossati, Sara, Franceschini, Erica, Gori, Andrea, Granata, Guido, Grignolo, Sara, Grossi, Paolo Antonio, Guadagnino, Giuliana, Lagi, Filippo, Maraolo, Alberto Enrico, Marinò, Valeria, Mazzitelli, Maria, Mularoni, Alessandra, Oliva, Alessandra, Pace, Maria Caterina, Parisini, Andrea, Patti, Francesca, Petrosillo, Nicola, Pota, Vincenzo, Raffaelli, Francesca, Rossi, Marianna, Santoro, Antonella, Tascini, Carlo, Torti, Carlo, Trecarichi, Enrico Maria, Venditti, Mario, Viale, Pierluigi, Signori, Alessio, Del Bono, Valerio, Giannella, Maddalena, Mikulska, Malgorzata, Tumbarello, Mario, Viscoli, Claudio, Passavanti, Maria Beatrice, Rogati, C, Sansone, Pasquale, Sarteschi, G, Roberto Giacobbe, Daniele, Saffioti1, Carolina, Raffaella Losito, Angela, Rinaldi, Matteo, Aurilio, Caterina, Bolla, Cesare, Boni, Silvia, Borgia, Guglielmo, Carannante, Novella, Cassola, Giovanni, Ceccarelli, Giancarlo, Corcione, Silvia, Dalla Gasperina, Daniela, Giuseppe De Rosa, Francesco, Dentone, Chiara, DI BELLA, Stefano, Di Lauria, Nicoletta, Feasi, Marcello, Fiore, Marco, Fossati, Sara, Franceschini, Erica, Gori, Andrea, Granata, Guido, Grignolo, Sara, Antonio Grossi, Paolo, Guadagnino, Giuliana, Lagi, Filippo, Enrico Maraolo, Alberto, Marinò, Valeria, Mazzitelli, Maria, Mularoni, Alessandra, Oliva, Alessandra, Caterina Pace, Maria, Parisini, Andrea, Patti, Francesca, Petrosillo, Nicola, Pota, Vincenzo, Raffaelli, Francesca, Rossi, Marianna, Santoro, Antonella, Tascini, Carlo, Torti, Carlo, Maria Trecarichi, Enrico, Venditti, Mario, Viale, Pierluigi, Signori, Alessio, Bassetti, Matteo, Del Bono, Valerio, Giannella, Maddalena, Mikulska, Malgorzata, Tumbarello, Mario, Viscoli, Claudio, Giacobbe, Daniele Roberto, Saffioti, Carolina, Losito, Angela Raffaella, Gasperina, Daniela Dalla, De Rosa, Francesco Giuseppe, Di Bella, Stefano, Grossi, Paolo Antonio, Maraolo, Alberto Enrico, Pace, Maria Caterina, Trecarichi, Enrico Maria, Passavanti, Maria Beatrice, Rogati, C, Sansone, Pasquale, Sarteschi, G, Giacobbe D.R., Saffioti C., Losito A.R., Rinaldi M., Aurilio C., Bolla C., Boni S., Borgia G., Carannante N., Cassola G., Ceccarelli G., Corcione S., Dalla Gasperina D., De Rosa F.G., Dentone C., Di Bella S., Di Lauria N., Feasi M., Fiore M., Fossati S., Franceschini E., Gori A., Granata G., Grignolo S., Grossi P.A., Guadagnino G., Lagi F., Maraolo A.E., Marino V., Mazzitelli M., Mularoni A., Oliva A., Pace M.C., Parisini A., Patti F., Petrosillo N., Pota V., Raffaelli F., Rossi M., Santoro A., Tascini C., Torti C., Trecarichi E.M., Venditti M., Viale P., Signori A., Bassetti M., Del Bono V., Giannella M., Mikulska M., Tumbarello M., and Viscoli C.
- Subjects
0301 basic medicine ,Male ,Endemic Diseases ,Drug Resistance ,Carbapenem-resistant enterobacteriaceae ,Pseudomona ,0302 clinical medicine ,Interquartile range ,Levofloxacin ,Drug Resistance, Multiple, Bacterial ,Klebsiella ,polycyclic compounds ,Acinetobacter ,Antimicrobial resistance ,Colistimethate ,Colistin ,Pseudomonas ,Administration, Intravenous ,Aged ,Anti-Bacterial Agents ,Cross-Sectional Studies ,Drug Prescriptions ,Drug Therapy, Combination ,Female ,Gram-Negative Bacterial Infections ,Humans ,Italy ,Middle Aged ,Respiratory Tract Infections ,Sepsis ,Immunology and Allergy ,030212 general & internal medicine ,colistin ,colistimethate ,Bacterial ,QR1-502 ,Administration ,Combination ,lipids (amino acids, peptides, and proteins) ,antimicrobial resistance ,Intravenous ,Multiple ,medicine.drug ,Microbiology (medical) ,medicine.medical_specialty ,Cefepime ,030106 microbiology ,Immunology ,Microbiology ,Loading dose ,03 medical and health sciences ,Drug Therapy ,Internal medicine ,Lower respiratory tract infection ,medicine ,business.industry ,biochemical phenomena, metabolism, and nutrition ,medicine.disease ,business - Abstract
Objectives The aim of this study was to assess colistin use in a country endemic for multidrug-resistant Gram-negative bacteria (MDR-GNB). Methods Colistin prescription patterns were evaluated in 22 Italian centres. Factors associated with use of colistin in combination with other anti-MDR-GNB agents were also assessed. Results A total of 221 adults receiving colistin were included in the study. Their median age was 64 years (interquartile range 52–73 years) and 134 (61%) were male. Colistin was mostly administered intravenously (203/221; 92%) and mainly for targeted therapy (168/221; 76%). The most frequent indications for colistin therapy were bloodstream infection and lower respiratory tract infection. Intravenous colistin was administered in combination with at least another anti-MDR-GNB agent in 80% of cases (163/203). A loading dose of 9 MU of colistimethate was administered in 79% of patients receiving i.v. colistin and adequate maintenance doses in 85%. In multivariable analysis, empirical therapy [odds ratio (OR) = 3.25, 95% confidence interval (CI) 1.24–8.53;P = 0.017] and targeted therapy for carbapenem-resistant Enterobacterales infection (OR = 4.76, 95% CI 1.69–13.43; P = 0.003) were associated with use of colistin in combination with other agents, whilst chronic renal failure (OR = 0.39, 95% CI 0.17–0.88; P = 0.024) was associated with use of colistin monotherapy. Conclusion Colistin remains an important option for severe MDR-GNB infections when other treatments are not available. Despite inherent difficulties in optimising its use owing to peculiar pharmacokinetic/pharmacodynamic characteristics, colistin was mostly used appropriately in a country endemic for MDR-GNB.
- Published
- 2020
30. Adherence to 2015 ESC Guidelines for the Treatment of Infective Endocarditis: A Retrospective Multicentre Study (LEIOT Study).
- Author
-
Pallotto C, Bolla C, Penpa S, Genga G, Sarda C, Svizzeretto E, Tommasi A, Stolaj E, Salvaderi A, Piceni G, Maconi A, Chichino G, Francisci D, and On Behalf Of The Leiot Study Group
- Abstract
Background: Infective endocarditis (IE) is still a severe disease with elevated morbidity and mortality. Nevertheless, the last European guidelines (GL) date back to 2015, and a recent survey described a diffuse suboptimal adherence to their recommendations. Here, we described a real-life scenario about adherence to IE treatment GL., Methods: This was a retrospective, multicentric, case-control study. All the cases of IE admitted to our wards from 2016 to 2020 were enrolled. Patients were divided into two groups, according to the non-adherence (group A, cases) or adherence (group B, controls) to 2015 ESC guidelines. Only targeted treatments were considered. Groups were compared for demographic, clinical, microbiological, and laboratory data and outcome. As a post hoc analysis, we analysed the characteristics of deviations from the guidelines and how these deviations affected mortality., Results: A total of 246 patients were enrolled, with 128 (52%) in group A and 118 (48%) in group B. Groups were homogeneous except for aetiologies: staphylococcal and blood-culture-negative IE were more frequent in group A, while streptococcal and enterococcal IE were more frequent in group B ( p < 0.001). In-hospital mortality was comparable in the two groups. The most frequent causes of deviations from the guidelines were use of daptomycin, in addition to standard treatments and the missing administration of rifampin or gentamycin., Conclusions: Adherence to 2015 ESC guidelines was limited but it did not affect mortality.
- Published
- 2023
- Full Text
- View/download PDF
31. Impact of septic episodes caused by Acinetobacter baumannii, Klebsiella pneumoniae and Pseudomonas aeruginosa in a tertiary hospital: clinical and economic considerations in years 2018-2020.
- Author
-
Garlasco J, Beqiraj I, Bolla C, Marino EMI, Zanelli C, Gualco C, Rocchetti A, and Gianino MM
- Subjects
- Humans, Klebsiella pneumoniae, Pseudomonas aeruginosa, Tertiary Care Centers, Retrospective Studies, Drug Resistance, Multiple, Bacterial, Microbial Sensitivity Tests, Anti-Bacterial Agents therapeutic use, Anti-Bacterial Agents pharmacology, Acinetobacter baumannii
- Abstract
Objective: To evaluate incidence, therapy and antibiotic resistance trends in septic episodes caused by three multi-drug resistant bacteria in a tertiary hospital, by also estimating their economic impact., Methods: An observational, retrospective-cohort analysis was based on data related to patients admitted to the "SS. Antonio e Biagio e Cesare Arrigo" Hospital in Alessandria (Italy) between 2018 and 2020, that developed sepsis from multi-drug resistant bacteria of the examined species. Data were retrieved from medical records and from the hospital's management department., Results: Inclusion criteria led to enrolment of 174 patients. A relative increase in A. baumannii cases (p < 0.0001) and an increasing resistance trend for K. pneumoniae (p < 0.0001) were detected in 2020 compared to 2018-2019. Most patients were treated with carbapenems (72.4%), although the use of colistin rose significantly in 2020 (62.5% vs 36%, p = 0.0005). Altogether, these 174 cases caused 3295 additional hospitalisation days (mean 19 days/patient): the consequent expenditure attained ≈ 3 million Euros, 85% of which (≈2.5 million Euros) due to the cost of extra hospital stay. Specific antimicrobial therapy accounted for 11.2% of the total (≈336,000 €)., Conclusions: Healthcare-related septic episodes cause a considerable burden. Moreover, a trend could be spotted towards higher relative incidence of complex cases recently., (Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
32. A Regional Observational Study on COVID-19-Associated Pulmonary Aspergillosis (CAPA) within Intensive Care Unit: Trying to Break the Mold.
- Author
-
Lupia T, Montrucchio G, Gaviraghi A, Musso G, Puppo M, Bolla C, Shbaklo N, Rizzello B, Della Selva A, Concialdi E, Rumbolo F, Barbui AM, Brazzi L, De Rosa FG, and Corcione S
- Abstract
The reported incidence of COVID-19-associated pulmonary aspergillosis (CAPA) ranges between 2.4% and 35% in intensive care unit (ICU) patients, and awareness in the medical community is rising. We performed a regional retrospective observational study including patients diagnosed with CAPA defined according to the Modified AspICU Dutch/Belgian Mycosis Study Group and CAPA-EECMM, from five different ICUs, admitted between March, 2020 and September, 2021. Forty-five patients were included. The median age was 64 (IQR 60-72), mostly (73%) males. At ICU admission, the median Charlson comorbidity index was 3 (2-5), and the simplified acute physiology score (SAPS)-II score was 42 (31-56). The main underlying diseases were hypertension (46%), diabetes (36%) and pulmonary diseases (15%). CAPA was diagnosed within a median of 17 days (IQR 10-21.75) after symptoms onset and 9 days (IQR 3-11) after ICU admission. The overall 28-day mortality rate was 58%, and at univariate analysis, it was significantly associated with older age ( p = 0.009) and SAPS-II score at admission ( p = 0.032). The use of immunomodulatory agents, p = 0.061; broad-spectrum antibiotics, p = 0.091; positive culture for Aspergillus on BAL, p = 0.065; and hypertension, p = 0.083, were near reaching statistical significance. None of them were confirmed in multivariate analysis. In critically ill COVID-19 patients, CAPA acquired clinical relevance in terms of incidence and reported mortality. However, the risk between underdiagnosis-in the absence of specific invasive investigations, and with a consequent possible increase in mortality-and over-diagnosis (case identification with galactomannan on broncho-alveolar fluid alone) might be considered. Realistic incidence rates, based on local, real-life epidemiological data, might be helpful in guiding clinicians.
- Published
- 2022
- Full Text
- View/download PDF
33. Factors Associated With Weight Gain in People Treated With Dolutegravir.
- Author
-
Taramasso L, Bonfanti P, Ricci E, Orofino G, Squillace N, Menzaghi B, De Socio GV, Madeddu G, Pellicanò GF, Pagnucco L, Celesia BM, Calza L, Conti F, Martinelli CV, Valsecchi L, Cascio A, Bolla C, Maggi P, Vichi F, Dentone C, Angioni G, Mastroianni A, Falasca K, Cenderello G, and Di Biagio A
- Abstract
Background: An unexpected excess in weight gain has recently been reported in the course of dolutegravir (DTG) treatment. The aim of the present study was to investigate whether weight gain differs among different DTG-containing regimens., Methods: Adult naïve and experienced people with HIV (PWH) initiating DTG-based antiretroviral therapy (ART) between July 2014 and December 2019 in the Surveillance Cohort Long-Term Toxicity Antiretrovirals (SCOLTA) prospective cohort were included. We used an adjusted general linear model to compare weight change among backbone groups and a Cox proportional hazard regression model to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) for weight increases >10% from baseline., Results: A total of 713 participants, 25.3% women and 91% Caucasian, were included. Of these, 195 (27.4%) started DTG as their first ART regimen, whereas 518 (72.6%) were ART-experienced. DTG was associated with abacavir/lamivudine in 326 participants, tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) in 148, boosted protease inhibitors in 60, rilpivirine in 45, lamivudine in 75, and tenofovir alafenamide (TAF)/FTC in 59. At 6 and 12 months, weight gain was highest among PWH on TDF/FTC+DTG and TAF/FTC+DTG. Baseline CD4 <200 cells/mm
3 (HR, 1.84; 95% CI, 1.15 to 2.96), being ART-naïve (HR, 2.24; 95% CI, 1.24 to 4.18), and treatment with TDF/FTC+DTG (HR, 1.92; 95% CI, 1.23 to 2.98) or TAF/FTC+DTG (HR, 3.80; 95% CI, 1.75 to 8.23) were associated with weight gain >10% from baseline. Higher weight (HR, 0.97 by 1 kg; 95% CI, 0.96 to 0.99) and female gender (HR, 0.54; 95% CI, 0.33 to 0.88) were protective against weight gain., Conclusions: Naïve PWH with lower CD4 counts and those on TAF/FTC or TDF/FTC backbones were at higher risk of weight increase in the course of DTG-based ART., (© The Author(s) 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America.)- Published
- 2020
- Full Text
- View/download PDF
34. Use of colistin in adult patients: A cross-sectional study.
- Author
-
Giacobbe DR, Saffioti C, Losito AR, Rinaldi M, Aurilio C, Bolla C, Boni S, Borgia G, Carannante N, Cassola G, Ceccarelli G, Corcione S, Dalla Gasperina D, De Rosa FG, Dentone C, Di Bella S, Di Lauria N, Feasi M, Fiore M, Fossati S, Franceschini E, Gori A, Granata G, Grignolo S, Grossi PA, Guadagnino G, Lagi F, Maraolo AE, Marinò V, Mazzitelli M, Mularoni A, Oliva A, Pace MC, Parisini A, Patti F, Petrosillo N, Pota V, Raffaelli F, Rossi M, Santoro A, Tascini C, Torti C, Trecarichi EM, Venditti M, Viale P, Signori A, Bassetti M, Del Bono V, Giannella M, Mikulska M, Tumbarello M, and Viscoli C
- Subjects
- Administration, Intravenous, Aged, Anti-Bacterial Agents therapeutic use, Colistin therapeutic use, Cross-Sectional Studies, Drug Prescriptions statistics & numerical data, Drug Therapy, Combination statistics & numerical data, Endemic Diseases, Female, Gram-Negative Bacterial Infections epidemiology, Humans, Italy epidemiology, Male, Middle Aged, Respiratory Tract Infections microbiology, Sepsis microbiology, Anti-Bacterial Agents administration & dosage, Colistin administration & dosage, Drug Resistance, Multiple, Bacterial, Gram-Negative Bacterial Infections drug therapy, Respiratory Tract Infections drug therapy, Sepsis drug therapy
- Abstract
Objectives: The aim of this study was to assess colistin use in a country endemic for multidrug-resistant Gram-negative bacteria (MDR-GNB)., Methods: Colistin prescription patterns were evaluated in 22 Italian centres. Factors associated with use of colistin in combination with other anti-MDR-GNB agents were also assessed., Results: A total of 221 adults receiving colistin were included in the study. Their median age was 64 years (interquartile range 52-73 years) and 134 (61%) were male. Colistin was mostly administered intravenously (203/221; 92%) and mainly for targeted therapy (168/221; 76%). The most frequent indications for colistin therapy were bloodstream infection and lower respiratory tract infection. Intravenous colistin was administered in combination with at least another anti-MDR-GNB agent in 80% of cases (163/203). A loading dose of 9 MU of colistimethate was administered in 79% of patients receiving i.v. colistin and adequate maintenance doses in 85%. In multivariable analysis, empirical therapy [odds ratio (OR) = 3.25, 95% confidence interval (CI) 1.24-8.53;P = 0.017] and targeted therapy for carbapenem-resistant Enterobacterales infection (OR = 4.76, 95% CI 1.69-13.43; P = 0.003) were associated with use of colistin in combination with other agents, whilst chronic renal failure (OR = 0.39, 95% CI 0.17-0.88; P = 0.024) was associated with use of colistin monotherapy., Conclusion: Colistin remains an important option for severe MDR-GNB infections when other treatments are not available. Despite inherent difficulties in optimising its use owing to peculiar pharmacokinetic/pharmacodynamic characteristics, colistin was mostly used appropriately in a country endemic for MDR-GNB., (Copyright © 2019 International Society for Antimicrobial Chemotherapy. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
35. Asymptomatic Leishmania infantum infection in an area of northwestern Italy (Piedmont region) where such infections are traditionally nonendemic.
- Author
-
Biglino A, Bolla C, Concialdi E, Trisciuoglio A, Romano A, and Ferroglio E
- Subjects
- Adult, Age Factors, Aged, Aged, 80 and over, Agriculture, Animals, Animals, Domestic, Blood parasitology, Blotting, Western methods, Carrier State parasitology, DNA, Protozoan genetics, DNA, Protozoan isolation & purification, Dogs, Female, Humans, Italy epidemiology, Leishmania infantum genetics, Leishmania infantum immunology, Leishmaniasis, Visceral parasitology, Leishmaniasis, Visceral pathology, Male, Middle Aged, Risk Factors, Rural Population, Young Adult, Antibodies, Protozoan blood, Carrier State epidemiology, Leishmania infantum isolation & purification, Leishmaniasis, Visceral epidemiology
- Abstract
The prevalence of Leishmania infantum-specific antibodies and asymptomatic infection was assessed in a randomized sample of 526 healthy adults from a continental area of northwestern Italy where L. infantum is not endemic and where autochthonous cases of visceral leishmaniasis (VL) were recently reported. L. infantum-specific antibodies were detected by Western blotting (WB) in 39 subjects (7.41%), while L. infantum kinetoplast DNA was amplified from buffy coat in 21 out of 39 WB-positive subjects, confirming asymptomatic infection in 53.8% of seropositives. Risk factors significantly associated with WB positivity were uninterrupted residence since childhood in a local rural environment (odds ratio [OR], 3.5; 95% confidence interval [CI], 1.7 to 7.3), daily contact with animals though not exclusively with dogs (OR, 3.7; 95% CI, 1.3 to 10.7), older age (OR, 2.31; 95% CI, 1.2 to 4.5), and agricultural/other outdoor activities (OR, 3.8; 95% CI, 0.99 to 3.7.) Logistic regression analysis showed that uninterrupted residence in a local rural environment and an age of >65 years were the only independent predictors of seropositivity assessed by WB. Follow-up at 24 months did not show evidence of VL in either seropositive or PCR-positive subjects. The detection of a high seroprevalence rate, confirmed as asymptomatic infection by PCR in more than half of the cases, among healthy residents in a continental area of northwestern Italy makes local L. infantum transmission very likely. In a region where VL is considered nonendemic, these findings warrant further epidemiological investigations as well as interventions with respect to both the canine reservoir and vectors, given the possible risks for immunosuppressed patients.
- Published
- 2010
- Full Text
- View/download PDF
36. Dogs' parasite and zoonotic risk: from old to new "emergencies" in the North-West of Italy.
- Author
-
Ferroglio E, Romano A, Passera S, D'Angelo A, Guiso P, Ghiggi E, Bolla C, Trisciuoglio A, and Biglino A
- Subjects
- Animals, Antibodies, Protozoan blood, Cat Diseases epidemiology, Cat Diseases transmission, Cats, Communicable Diseases, Emerging transmission, Communicable Diseases, Emerging veterinary, Disease Reservoirs, Dog Diseases blood, Dog Diseases transmission, Dogs, Feces parasitology, Humans, Insect Vectors parasitology, Italy epidemiology, Leishmania infantum immunology, Leishmania infantum isolation & purification, Leishmaniasis, Visceral epidemiology, Leishmaniasis, Visceral transmission, Oocysts isolation & purification, Parasitic Diseases, Animal blood, Parasitic Diseases, Animal transmission, Phlebotomus parasitology, Polymerase Chain Reaction, Polymorphism, Restriction Fragment Length, Risk, Seroepidemiologic Studies, Soil parasitology, Toxocariasis transmission, Zoonoses, Communicable Diseases, Emerging epidemiology, Dog Diseases epidemiology, Leishmaniasis, Visceral veterinary, Parasitic Diseases, Animal epidemiology, Toxocariasis epidemiology
- Abstract
Toxocariasis due to soil contamination from dog and cat faeces has been long described and represents one of the zoonotic risk linked with pets presence in human settlements. Soil samples were collected from private backyards and school playgrounds in Turin and tested for the presence of Toxocara spp. eggs. Samples from dogs and cats living in the same area were also analysed and our results seem to indicate a decrease in soil contamination respect to a survey carried out in 1985. Considering that recently new foci of Canine Leishmaniosis and the presence of competent sand fly vectors have also been reported in the North-West of Italy, a survey was carried out on dogs and humans living in Asti province. To assess the risk of local Leishmania infantum transmission between dog and humans, samples were also analysed by Restriction Fragment Length Polymorphism (PCR-RFLP). Our results have shown that more than 10% of autochthonous dogs and human being living in this previously non-endemic area have been infected by L. infantum. The identity of PCR-RFLP patterns from 3 human clinical cases and from the dogs of one of them allows us to confirm the autochthonous origin of these cases.
- Published
- 2006
37. Collaboration versus competition: results of an academic practice alliance.
- Author
-
Ganley B, Sheets I, Buccheri R, Thomas SA, Doerr-Kashani P, Widergren R, Bolla C, Stoker D, and West D
- Subjects
- Adult, Attitude of Health Personnel, Cooperative Behavior, Education, Nursing, Baccalaureate organization & administration, Faculty, Nursing, Female, Humans, Male, Middle Aged, Models, Nursing, Needs Assessment, Nursing Education Research, Preceptorship organization & administration, Program Development, Program Evaluation, San Francisco, Students, Nursing psychology, Surveys and Questionnaires, United States, Community Health Nursing education, Community Health Nursing organization & administration, Community Networks organization & administration, Interinstitutional Relations, Schools, Nursing organization & administration, United States Public Health Service organization & administration
- Abstract
In 2002, a Community Academic Practice Alliance (CAPA) was forged between Marin County, Department of Health and Human Services (DHHS), and local bachelor of science in nursing (BSN) nursing programs. This alliance has increased opportunities for DHHS to recruit new baccalaureate registered nurses, eliminated competition among universities for community health nursing (CHN) placements, enriched experiences for BSN students, and enhanced service to the community. This article describes the development process and examines preceptor, faculty, and student satisfaction. It also describes students' attitudes toward CHN and public health nursing, which increased significantly (p < .001, 95% confidence interval of 1.11-2.14). Process evaluation (17 Likert items, on a scale ranging from 1 [low] to 4 [high]) revealed a mean of 3.30 with a standard deviation of 0.328 suggesting CAPA members' satisfaction with the process. This project was presented at the American Public Health Association 131st annual meeting, San Francisco, California, November 2003.
- Published
- 2004
- Full Text
- View/download PDF
38. Adrenal location of the echinococcus. Considerations on a clinical case.
- Author
-
Toppino M, Serra GC, Bolla C, Capalbo MT, Capuzzi P, Comorio A, and Mistrangelo M
- Abstract
Adrenal location of a hydatic cyst is a clinical occurrence of exceptional rarity, especially in its primitive form and it could be evaluated, on the operative and autoptic comparison, not to exceed overall 0.5% of all the possible locations. Moreover, among all the cystic formations of the adrenal glands, parasitic ones are only 7%. Our observation of a case of adrenal hydatidosis, initially suspected as hepatic mass, was casually discovered by means of abdominal ultrasonography and later confirmed with the operation. This work contributes to the knowledge of this pathology, emphasizing diagnostic difficulties, and, considering the exiguous literature, helping us in supplying real indications to the surgical treatment.
- Published
- 1996
39. Social support as road map and vehicle: an analysis of data from focus group interviews with a group of African American women.
- Author
-
Di Martile Bolla C, De Joseph J, Norbeck J, and Smith R
- Subjects
- Attitude to Health ethnology, Community Health Nursing, Female, Focus Groups, Humans, Nursing Methodology Research, Patient Care Team, Pregnancy, Black or African American psychology, Health Services Needs and Demand, Poverty, Pregnancy Outcome ethnology, Social Support
- Abstract
As part of a larger study of the impact of a social support intervention on pregnancy outcome for lower-income African American women, 6 African American women (a medical social worker, a physician's assistant, 2 community outreach workers, a lactation consultant, and a health project representative) participated in focus group discussions concerning the unique social support needs of lower-income African American women during pregnancy. Transcripts of focus group interviews were analyzed using qualitative content analysis. Emergent themes included strengths of African American communities, deficiencies in social support for many lower-income African American women, the meaning of pregnancy for African American women, the ability of many pregnant women to "make it" without visible means of support, young women's locations "inside" and "outside" of "mainstream" life, and the importance of social support as a mechanism for guiding and transporting "lost souls" back into the mainstream.
- Published
- 1996
- Full Text
- View/download PDF
40. [Extrahepatic gastrinoma. Report of a clinical case].
- Author
-
Toppino M, Corno F, Serra GC, Mistrangelo M, Guglielminotti P, Bolla C, Comba A, Capuzzi P, and Morino F
- Subjects
- Diagnosis, Differential, Female, Humans, Lymph Node Excision, Lymph Nodes pathology, Lymph Nodes surgery, Middle Aged, Zollinger-Ellison Syndrome diagnosis, Gastrinoma diagnosis, Gastrinoma pathology, Gastrinoma surgery, Lymphatic Metastasis, Neoplasms, Unknown Primary, Neuroendocrine Tumors diagnosis, Neuroendocrine Tumors pathology, Neuroendocrine Tumors surgery
- Abstract
Gastrinoma is a rare neoplasia producing gastrina, the hormone responsible of the clinic manifestations related to Zollinger-Ellison syndrome. The localization of gastrinoma is pancreatic or extrapancreatic (usually in Stabile and Passaro triangle). We present a case report concerning an extra-pancreatic gastrinoma not localized in this area and included in a lymph node. This is an extremely infrequent localization (2.4%). There are two different opinions about this localization. Some authors think that this is always a secondary lesion of a small primary neoplasia usually asymptomatic. Other authors think that there are primary lymph nodal gastrinomas that could be safely removed with excision of lymph node. The infrequent localisation of this case induced us to report this experience in order to contribute to the comprehension of this pathology.
- Published
- 1996
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.